# Liraglutide vs semaglutide STEP 8: weight loss at 68 weeks

Source: https://pepvault.app/research/liraglutide-step-8-2022

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Liraglutide](https://pepvault.app/research#liraglutide)

Randomized trial · people

# Liraglutide: 6.4% weight loss vs 15.8% on semaglutide in STEP 8

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this head-to-head trial, daily liraglutide led to less weight loss than weekly semaglutide over 68 weeks, and more people stopped taking it, while gut side effects were similar for both.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 338
- **Published:** 2022
- **Journal:** JAMA

## What they tested

The team compared how much weight people lost, and what side effects they had, on daily liraglutide versus weekly semaglutide.

## How the study was done

A randomized phase 3b trial at 19 US sites in 338 adults with overweight or obesity and no diabetes, who received daily liraglutide 3.0 mg, weekly semaglutide 2.4 mg or placebo (a dummy shot) for 68 weeks, along with diet and physical activity advice. Participants knew which of the two drugs they were on, but neither drug group knew whether they had the drug or its matching placebo.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking liraglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At 68 weeks, body weight fell by 6.4% on average in the liraglutide arm, compared with 15.8% in the semaglutide arm and 1.9% with pooled placebo, a difference between the two drugs of -9.4 percentage points. A loss of 10% or more was reached by 25.6% of people on liraglutide versus 70.9% on semaglutide, and a loss of 20% or more by 6.0% versus 38.5%. More people stopped liraglutide than semaglutide (27.6% vs 13.5%). Stomach and gut side effects were about as common in both arms: 82.7% with liraglutide and 84.1% with semaglutide.

## What it doesn’t show

The two drugs were compared open-label, so participants knew which one they were taking. The trial included only adults without diabetes, mostly women (78.4%), at US sites, and it lasted 68 weeks.

## The paper

Rubino et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022.

- [PubMed (PMID 35015037)](https://pubmed.ncbi.nlm.nih.gov/35015037/)
- [The paper (DOI 10.1001/jama.2021.23619)](https://doi.org/10.1001/jama.2021.23619)
- [ClinicalTrials.gov (NCT04074161)](https://clinicaltrials.gov/study/NCT04074161)

## The compounds

- [Liraglutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/liraglutide)
- [Semaglutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/semaglutide)
- [Liraglutide dose guide](https://pepvault.app/lab/dosage/liraglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

## With this study

### Liraglutide

- [Liraglutide: the full reference](https://pepvault.app/peptides/liraglutide)
- [Liraglutide dose guide](https://pepvault.app/lab/dosage/liraglutide)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Liraglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/liraglutide-10mg)
- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Liraglutide plus exercise: 9.5 kg more loss than placebo at 1 year](https://pepvault.app/research/liraglutide-lundgren-2021)
- [Liraglutide: 13.0% vs 14.9% major cardiovascular events in LEADER](https://pepvault.app/research/liraglutide-leader-2016)
- [All 4 studies](https://pepvault.app/research#liraglutide)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026)
- [All 20 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on Liraglutide

- [Liraglutide plus exercise: 9.5 kg more loss than placebo at 1 year](https://pepvault.app/research/liraglutide-lundgren-2021) Randomized trial · people · 2021
- [Liraglutide: 13.0% vs 14.9% major cardiovascular events in LEADER](https://pepvault.app/research/liraglutide-leader-2016) Randomized trial · people · 2016
- [Liraglutide: 8.4 kg lost vs 2.8 kg on placebo at 56 weeks](https://pepvault.app/research/liraglutide-scale-obesity-and-prediabetes-2015) Randomized trial · people · 2015
- [Every study on Liraglutide](https://pepvault.app/research#liraglutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking liraglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking liraglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Liraglutide

- [Liraglutide: the full reference](https://pepvault.app/peptides/liraglutide)
- [Liraglutide dose guide](https://pepvault.app/lab/dosage/liraglutide)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Liraglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/liraglutide-10mg)
- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Liraglutide plus exercise: 9.5 kg more loss than placebo at 1 year](https://pepvault.app/research/liraglutide-lundgren-2021)
- [Liraglutide: 13.0% vs 14.9% major cardiovascular events in LEADER](https://pepvault.app/research/liraglutide-leader-2016)
- [All 4 studies](https://pepvault.app/research#liraglutide)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026)
- [All 20 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking liraglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Liraglutide](https://pepvault.app/research#liraglutide)

## The library

- [Liraglutide](https://pepvault.app/peptides/liraglutide)
- [Liraglutide dose guide](https://pepvault.app/lab/dosage/liraglutide)
- [Semaglutide](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza and Trulicity are trademarks of their respective owners; PepVault is independent and not affiliated with or endorsed by any manufacturer.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
